The role of protein p53 in neurodegenerative processes throughout the 25 years of its history

被引:3
作者
Gómez-Lázaro, M [1 ]
Fernández-Gómez, FJ [1 ]
Jordán, J [1 ]
机构
[1] Univ Castilla La Mancha, Ctr Reg Invest Biomed, Dept Ciencias Med, Fac Med, E-02006 Albacete, Spain
关键词
apoptosis; cancer; cell cycle; genome; mitochondria; neurodegeneration; p53; transcription factors;
D O I
10.33588/rn.3903.2004355
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Aims. In this review we will stud), the role of protein p53 in neurodegenerative processes and conduct a detailed analysis of the mechanisins responsible for regulating its levels and biological activity. We analyse the neuropathologies in which this protein is involved, such as Alzheimer's and Parkinson's diseases and amyotrophic lateral sclerosis, and we will also examine its regulation by second messengers such as the reactive species of oxygen and calcium, showing the signalling paths involved in the apoptotic processes. Development. The year 2004 sees the 25th anniversary of the discovery of protein p53. At first p53 was wrongly attributed with an oncogenic function due to its capacity to bind to the T antigen of the virus SV40 in transformed cells. Nevertheless, it was not until 1989 that it was attributed with its true physiological function as a tumour-suppressing protein. This milestone constitutes a turning point in the short life of this protein. Conclusions. Protein p53 plays all essential role in the mechanisms by, which the cell responds to damage or mutation in the genome. It can activate two signalling mechanisms that lead either to stopping the cell cycle or to the death of the cell due to apoptosis if the cell cannot repair the damage to the genome. There is a correlation between its deletions and mutations and the development of cancel; and increases in its native from have been described in pathologies where apoptotic processes are high, as is the case of some neurodegenerative diseases.
引用
收藏
页码:243 / 250
页数:8
相关论文
共 126 条
[1]
DNA damage and apoptosis in Alzheimer's disease: Colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay [J].
Anderson, AJ ;
Su, JH ;
Cotman, CW .
JOURNAL OF NEUROSCIENCE, 1996, 16 (05) :1710-1719
[2]
Anglade P, 1997, HISTOL HISTOPATHOL, V12, P25
[3]
HIGH-FREQUENCY DEVELOPMENTAL ABNORMALITIES IN P53-DEFICIENT MICE [J].
ARMSTRONG, JF ;
KAUFMAN, MH ;
HARRISON, DJ ;
CLARKE, AR .
CURRENT BIOLOGY, 1995, 5 (08) :931-936
[4]
Death receptors: Signaling and modulation [J].
Ashkenazi, A ;
Dixit, VM .
SCIENCE, 1998, 281 (5381) :1305-1308
[5]
BAKDWIN HA, 1993, BRIT J PHARMACOL, V108, P590
[6]
MDM2 EXPRESSION IS INDUCED BY WILD TYPE-P53 ACTIVITY [J].
BARAK, Y ;
JUVEN, T ;
HAFFNER, R ;
OREN, M .
EMBO JOURNAL, 1993, 12 (02) :461-468
[7]
A PROTEOLYTIC FRAGMENT FROM THE CENTRAL REGION OF P53 HAS MARKED SEQUENCE-SPECIFIC DNA-BINDING ACTIVITY WHEN GENERATED FROM WILD-TYPE BUT NOT FROM ONCOGENIC MUTANT P53-PROTEIN [J].
BARGONETTI, J ;
MANFREDI, JJ ;
CHEN, XB ;
MARSHAK, DR ;
PRIVES, C .
GENES & DEVELOPMENT, 1993, 7 (12B) :2565-2574
[8]
COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system [J].
Bech-Otschir, D ;
Kraft, R ;
Huang, XH ;
Henklein, P ;
Kapelari, B ;
Pollmann, C ;
Dubiel, W .
EMBO JOURNAL, 2001, 20 (07) :1630-1639
[9]
HYDROGEN-PEROXIDE MEDIATES AMYLOID-BETA PROTEIN TOXICITY [J].
BEHL, C ;
DAVIS, JB ;
LESLEY, R ;
SCHUBERT, D .
CELL, 1994, 77 (06) :817-827
[10]
Programmed cell death: Does it play a role in Parkinson's disease? [J].
Burke, RE ;
Kholodilov, NG .
ANNALS OF NEUROLOGY, 1998, 44 (03) :S126-S133